Literature DB >> 4006133

Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs.

M Matsuzaki, B Guth, T Tajimi, W S Kemper, J Ross.   

Abstract

The effect of combination therapy with diltiazem and atenolol on the regional myocardial blood flow-function relationship was studied in eight conscious dogs with chronic coronary artery stenosis. An ameroid constrictor and hydraulic occluder were placed around the left circumflex coronary artery, sonomicrometers were implanted for measuring wall thickness in control and ischemic regions, and regional myocardial blood flow was measured with the microsphere method. Eighteen days (average) after surgery, resting regional myocardial function and blood flow were normal, but treadmill exercise induced severe regional myocardial dysfunction in the posterior wall (wall thickening during systole reduced from 25.5% to 2.7%, a 90% reduction). Subendocardial blood flow decreased by 68% from the control standing value, while subepicardial flow increased. An identical exercise bout was performed 3 hr after administration of atenolol (1.0 mg/kg orally) and 15 min after administration of diltiazem (0.3 mg/kg iv). Heart rate during running was significantly lower as were left ventricular peak systolic pressure, end-diastolic pressure, and peak dP/dt. Wall thickening in the control region was not augmented during exercise after atenolol and diltiazem. There was less dysfunction in the ischemic region (35% reduction) and the improved performance was accompanied by a substantial increase in subendocardial perfusion (0.31 +/- 0.14 vs 0.61 +/- 0.30 ml/min/g, a 36% reduction from rest). Epicardial flow was unchanged, and the endocardial/epicardial ratio increased (0.27 +/- 0.13 vs 0.62 +/- 0.29). Recovery time for regional wall thickening also improved. The beneficial effects of the combination of atenolol and diltiazem in a preparation of single-vessel chronic coronary stenosis were shown to be significantly greater than those of either drug alone.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4006133     DOI: 10.1161/01.cir.72.1.233

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  The relation of contractile function to myocardial perfusion. Perfusion-contraction match and mismatch.

Authors:  G Heusch; R Schulz
Journal:  Herz       Date:  1999-11       Impact factor: 1.443

Review 2.  Myocardial perfusion and contraction in acute ischemia and chronic ischemic heart disease.

Authors:  John M Canty; Gen Suzuki
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

3.  Mechanical and biochemical injury of spinal nerve roots: a morphological and neurophysiological study.

Authors:  M Cornefjord; K Olmarker; R Rydevik; C Nordborg
Journal:  Eur Spine J       Date:  1996       Impact factor: 3.134

Review 4.  Calcium channel antagonism and beta blockade in combination--a therapeutic alternative in cardiovascular disorders. A review.

Authors:  J N Lessem; B N Singh
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

5.  Myocardial ischemia: lack of coronary blood flow, myocardial oxygen supply-demand imbalance, or what?

Authors:  Gerd Heusch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-19       Impact factor: 4.733

Review 6.  The relationship between regional blood flow and contractile function in normal, ischemic, and reperfused myocardium.

Authors:  G Heusch
Journal:  Basic Res Cardiol       Date:  1991 May-Jun       Impact factor: 17.165

Review 7.  Role of calcium channel blockers in experimental exercise-induced ischemia.

Authors:  E Thaulow; B D Guth; J Ross
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

8.  Antifibrillatory effects of clofilium in the rabbit isolated heart.

Authors:  G S Friedrichs; L Chi; A L Green; B R Lucchesi
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

Review 9.  Heart rate in the pathophysiology of coronary blood flow and myocardial ischaemia: benefit from selective bradycardic agents.

Authors:  G Heusch
Journal:  Br J Pharmacol       Date:  2008-01-28       Impact factor: 8.739

Review 10.  Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia.

Authors:  R Schulz; B D Guth; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.